Brought to you by 
Insulet sells $120.8mm of debt
11 Jul 2011
Executive Summary
Insulet Corp., maker of the OmniPod insulin management system for diabetics, has netted $120.8mm through the private placement of 3.75% five-year convertible senior notes. The notes convert into 38.2 shares per $1k in principal at $26.20 each. Some of the funds may be used to repurchase $70mm in notes that are due in 2013.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Medical Devices
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Insulet sells $120.8mm of debt
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice